Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Publication year range
1.
MycoKeys ; 108: 15-45, 2024.
Article in English | MEDLINE | ID: mdl-39220353

ABSTRACT

During a survey of the diversity of lignicolous fungi in Yunnan Province, China, we collected and identified five microfungi species from dead woody litters of Castanopsis trees in terrestrial habitats. Through both morphological comparisons and phylogenetic analyses of multi-gene sequences, we identified two taxa as new species and three collections as new host records within Pleosporales. Pseudolophiostomalincangense sp. nov. is introduced as a sexual morph in Lophiostomataceae, Pleopunctumbaoshanense sp. nov. is introduced as a hyphomycetous fungi in Phaeoseptaceae, and Paraphomaaquatica as a first report of sexual morph in Paraphoma. In addition, Occultibambusakunmingensis and Pleopunctummegalosporum were isolated for the first time from the dead twigs of Castanopsisdelavayi and C.calathiformis, respectively. Comprehensive morphological descriptions, illustrations, and phylogenetic analysis results are provided for the above-mentioned species.

2.
J Ethnopharmacol ; 334: 118586, 2024 Nov 15.
Article in English | MEDLINE | ID: mdl-39032664

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Acquired resistance to osimertinib limits its clinical efficacy in non-small cell lung cancer (NSCLC) with EGFR mutations. The widespread recognition of Taxus chinensis var. Mairei (Lemée et Lévl) Cheng et L.K. Fu (Chinese yew) as a natural anti-cancer medication is well-established. However, the specific contribution of Taxus chinensis var. Mairei (Lemée et Lévl) Cheng et L.K. Fu in addressing resistance to osimertinib is still uncertain. AIM OF THE STUDY: Based on the biological behaviors and lipid metabolism, we investigated whether aqueous extract of Taxus chinensis var. Mairei (Lemée et Lévl) Cheng et L.K. Fu (AETC) could enhance the antitumor effect of osimertinib in NSCLC with an investigation on the precise mechanisms. MATERIALS AND METHODS: The effect of AETC on enhancing osimertinib sensitivity was assessed via cell viability measurements, levels of reactive oxygen species (ROS), apoptosis, and lipid levels. Western blotting was used to verify the mechanisms of AETC responsible for overcoming the resistance to osimertinib via ERK1/2 overexpression and knockdown models. In vivo validation was conducted using subcutaneous xenografts from osimertinib-resistant cells in nude mice. RESULTS: Osimertinib-resistant cells exhibited altered cholesterol biosynthesis, which was induced by ERK1/2 activation. The combination of AETC and osimertinib can synergistically decrease the levels of ROS in cells, enhance apoptosis, and inhibit the growth of osimertinib-resistant cells. Mechanistic experiments demonstrated that AETC can downregulate the key regulators of cholesterol biosynthesis by regulating ERK1/2, inhibiting the endogenous synthesis rate of cholesterol, and suppressing the level of lipids in osimertinib-resistant cells and xenograft tumors when combined with osimertinib, ultimately reversing resistance to osimertinib. CONCLUSIONS: The resistance to osimertinib is significantly influenced by cholesterol biosynthesis, highlighting its pivotal role in this context. AETC can enhance osimertinib sensitivity via ERK/SREBP-2/HMGCR-mediated cholesterol biosynthesis. These results provide a promising therapeutic target and potential treatment option for resistance to osimertinib.


Subject(s)
Acrylamides , Aniline Compounds , Carcinoma, Non-Small-Cell Lung , Cholesterol , Drug Resistance, Neoplasm , ErbB Receptors , Lung Neoplasms , Taxus , Animals , Female , Humans , Mice , Acrylamides/pharmacology , Aniline Compounds/pharmacology , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/genetics , Carcinoma, Non-Small-Cell Lung/metabolism , Carcinoma, Non-Small-Cell Lung/pathology , Cell Line, Tumor , Cholesterol/biosynthesis , Drug Resistance, Neoplasm/drug effects , ErbB Receptors/genetics , ErbB Receptors/metabolism , Indoles , Lung Neoplasms/drug therapy , Lung Neoplasms/genetics , Lung Neoplasms/pathology , MAP Kinase Signaling System/drug effects , Mice, Inbred BALB C , Mice, Nude , Mutation , Plant Extracts/pharmacology , Pyrimidines , Xenograft Model Antitumor Assays
3.
Cell Prolif ; : e13656, 2024 May 21.
Article in English | MEDLINE | ID: mdl-38773710

ABSTRACT

Melatonin (MLT) is a circadian hormone that reportedly influences the development and cyclic growth of secondary hair follicles; however, the mechanism of regulation remains unknown. Here, we systematically investigated the role of MLT in hair regeneration using a hair depilation mouse model. We found that MLT supplementation significantly promoted hair regeneration in the hair depilation mouse model, whereas supplementation of MLT receptor antagonist luzindole significantly suppressed hair regeneration. By analysing gene expression dynamics between the MLT group and luzindole-treated groups, we revealed that MLT supplementation significantly up-regulated Wnt/ß-catenin signalling pathway-related genes. In-depth analysis of the expression of key molecules in the Wnt/ß-catenin signalling pathway revealed that MLT up-regulated the Wnt/ß-catenin signalling pathway in dermal papillae (DP), whereas these effects were facilitated through mediating Wnt ligand expression levels in the hair follicle stem cells (HFSCs). Using a DP-HFSCs co-culture system, we verified that MLT activated Wnt/ß-catenin signalling in DPs when co-cultured with HFSCs, whereas supplementation of DP cells with MLT alone failed to activate Wnt/ß-catenin signalling. In summary, our work identified a critical role for MLT in promoting hair regeneration and will have potential implications for future hair loss treatment in humans.

4.
Integr Cancer Ther ; 23: 15347354241237969, 2024.
Article in English | MEDLINE | ID: mdl-38462913

ABSTRACT

Jixueteng, the vine of the bush Spatholobus suberectus Dunn., is widely used to treat irregular menstruation and arthralgia. Yinyanghuo, the aboveground part of the plant Epimedium brevicornum Maxim., has the function of warming the kidney to invigorate yang. This research aimed to investigate the effects and mechanisms of the Jixueteng and Yinyanghuo herbal pair (JYHP) on cisplatin-induced myelosuppression in a mice model. Firstly, ultra-high performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) screened 15 effective compounds of JYHP decoction. Network pharmacology enriched 10 genes which may play a role by inhibiting the apoptosis of bone marrow (BM) cells. Then, a myelosuppression C57BL/6 mice model was induced by intraperitoneal (i.p.) injection of cis-Diaminodichloroplatinum (cisplatin, CDDP) and followed by the intragastric (i.g.) administration of JYHP decoction. The efficacy was evaluated by blood cell count, reticulocyte count, and histopathological analysis of bone marrow and spleen. Through the vivo experiments, we found the timing of JYHP administration affected the effect of drug administration, JYHP had a better therapeutical effect rather than a preventive effect. JYHP obviously recovered the hematopoietic function of bone marrow from the peripheral blood cell test and pathological staining. Flow cytometry data showed JYHP decreased the apoptosis rate of BM cells and the western blotting showed JYHP downregulated the cleaved Caspase-3/Caspase-3 ratios through RAS/MEK/ERK pathway. In conclusion, JYHP alleviated CDDP-induced myelosuppression by inhibiting the apoptosis of BM cells through RAS/MEK/ERK pathway and the optimal timing of JYHP administration was after CDDP administration.


Subject(s)
Cisplatin , Drugs, Chinese Herbal , Mice , Animals , Female , Cisplatin/adverse effects , Caspase 3 , Network Pharmacology , Mice, Inbred C57BL , Drugs, Chinese Herbal/pharmacology , Mitogen-Activated Protein Kinase Kinases
5.
Integr Cancer Ther ; 23: 15347354231226108, 2024.
Article in English | MEDLINE | ID: mdl-38240227

ABSTRACT

OBJECTIVE: In China, grade 2 to 3 immune-related rash will probably lead to the interruption of immunotherapy. Corticosteroid (CS) is the main treatment, but not always effective. The external application of clearing heat and removing dampness, which is represented by Qing-Re-Li-Shi Formula (QRLSF), has been used in our hospital to treat immune-related cutaneous adverse events (ircAEs) for the last 5 years. The purpose of this study was to discuss its efficacy and safety in the treatment of grade 2 to 3 rash. METHODS: A retrospective study of patients with grade 2 to 3 immune-related rash in our hospital from December 2019 to December 2022 was conducted. These patients received QRLSF treatment. Clinical characteristics, treatment outcome, and health-related quality of life (HrQoL) were analyzed. RESULTS: Thirty patients with grade 2 to 3 rash (median onset time: 64.5 days) were included. The skin lesions of 24 cases (80%) returned to grade 1 with a median time of 8 days. The accompanying symptoms were also improved with median time of 3 to 4 days. The addition of antihistamine (AH) drug didn't increase the efficacy of QRLSF (AH + QRLSF: 75.00% vs QRLSF: 83.33%, P = .66). No significant difference was observed in the efficacy of QRLSF treatment regardless of whether patients had previously received CS therapy (untreated population: 88.24% vs treated population: 69.23%, P = .36). During 1-month follow-up, 2 cases (8.33%) underwent relapses. In terms of HrQoL, QRLSF treatment could significantly reduce the median scores of all domains of Skindex-16, including symptoms (39.58 vs 8.33, P < .0001), emotions (58.33 vs 15.48, P < .0001), functioning (46.67 vs 13.33, P < .0001) and composite (52.60 vs 14.06, P < .0001). CONCLUSION: External application of clearing heat and removing dampness was proven to be an effective and safe treatment for such patients. In the future, high-quality trials are required to determine its clinical application in the field of ircAEs.


Subject(s)
B7-H1 Antigen , Exanthema , Programmed Cell Death 1 Receptor , Humans , B7-H1 Antigen/antagonists & inhibitors , Exanthema/chemically induced , Exanthema/drug therapy , Hot Temperature , Ligands , Programmed Cell Death 1 Receptor/antagonists & inhibitors , Quality of Life , Retrospective Studies
6.
Biomed Pharmacother ; 154: 113628, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36058145

ABSTRACT

Immunoglobulin protein CD47 is overexpressed in malignant tumor cells, allowing them to evade host immunity mainly by inhibiting macrophage-mediated phagocytosis. Taxus chinensis var. mairei (TC) exhibits high antitumor efficacy with low toxicity and notable cost-effectiveness. However, it is unknown whether aqueous extract of TC (AETC) is an immunomodulator that mediates antitumor efficacy. In this study, we aimed to elucidate the critical role of CD47 degradation in the treatment of AETC in non-small cell lung cancer (NSCLC) cells. A mouse Lewis lung carcinoma model was developed to determine whether the administration of AETC, as an anti-CD47 antibody, in combination with anti-PD-1 could synergistically inhibit tumor growth and promote a peripheral immune response. AETC treatment downregulated CD47 levels in NSCLC cells and Lewis tumor xenograft mice. Furthermore, treatment enhanced immunity against NSCLC by triggering CD47 ubiquitination and degradation, promoting macrophage-mediated tumor cell phagocytosis, and activating CD8+ T cells. The present study empirically demonstrated, for the first time, that AETC exerts antitumor properties as an immunomodulator. Our findings present AETC as a promising alternative or adjuvant treatment in lung cancer therapy.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Taxus , Animals , CD47 Antigen , CD8-Positive T-Lymphocytes/metabolism , Carcinoma, Non-Small-Cell Lung/drug therapy , Heterografts , Humans , Lung Neoplasms/pathology , Mice
7.
Pharm Biol ; 59(1): 1294-1304, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34543169

ABSTRACT

CONTEXT: Yang-Yin-Jie-Du Decoction (YYJDD) was used to improve gefitinib efficacy in our clinical practice, but its mechanism remains unclear. OBJECTIVE: This study explored if YYJDD could reverse gefitinib resistance. MATERIALS AND METHODS: H1975 cells were exposed to control, 10 µM gefitinib, 3.2 mg/mL YYJDD or combination treatment. Cell viability was detected by MTT during 0-96 h. Apoptosis and the PI3K/Akt proteins were tested by flow cytometry and western-blot at 24 h. LY294002 was applied to further determine the role of the PI3K/Akt. 23 BALB/c nude xenograft mice received normal saline (n = 5), 80 mg/kg gefitinib (n = 6), 2.35 g/kg lyophilised powder of YYJDD (n = 6) or combination treatment (n = 6) by gavage for 4 weeks and submitted to TUNEL, immunohistochemistry, and western-blot. RESULTS: In vitro, gefitinib (IC50: 20.68 ± 2.06 µM) and YYJDD (IC50: 6.6 ± 0.21 mg/mL) acted in a moderate synergistic way. Combination treatment inhibited cell viability from 100% to 25.66%. Compared to gefitinb (33.23 ± 3.99%), cell apoptosis was increased with combination treatment (54.11 ± 7.32%), accompanied by down-regulation of the PI3K/Akt. LY294002 further inhibited cell viability, increased apoptosis, and down-regulated p-Akt/Akt. In vivo, the tumour sizes in the combination group (1165.13 ± 157.79 mm3) were smaller than gefitinib alone (1630.66 ± 208.30 mm3). The positive rate of TUNEL staining was increased by combination treatment (22.33 ± 2.75%) versus gefitinib (7.37 ± 0.87%), while the PI3K/Akt was down-regulated. DISCUSSION AND CONCLUSION: YYJDD has potential to overcome gefitinib resistance. Future investigations should be focussed on its specific targets.


Subject(s)
Carcinoma, Non-Small-Cell Lung/drug therapy , Drugs, Chinese Herbal/pharmacology , Gefitinib/pharmacology , Lung Neoplasms/drug therapy , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Down-Regulation/drug effects , Drug Resistance, Neoplasm/drug effects , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , Phosphatidylinositol 3-Kinase/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/drug effects , Xenograft Model Antitumor Assays
8.
Ying Yong Sheng Tai Xue Bao ; 25(8): 2243-50, 2014 Aug.
Article in Chinese | MEDLINE | ID: mdl-25509074

ABSTRACT

To inquire the different performances of the leaves and fruit quality of Fuji apple tress at various altitudes and their responses to the environmental factors, indices including leaf morphology, anatomy, δ13 C, and fruit quality of the Fuji apple trees at respective altitudes of 1375 m, 1575 m and 1715 m were investigated and their responses to environmental factors were determined following stepwise regression analysis. The results showed that 6 factors like the warmth index, Bailey's index, photosynthetically active radiation (PAR), coldness index, ultraviolet B and the annual precipitation dominantly affected the characteristic parameters of leaves and fruit. Elevation increase was matched by the decreasing warmth index, rising Bailey' s index, intenser PAR, higher coldness index, stronger ultraviolet B and heavier annual precipitation; meanwhile, the leaf structure and fruit quality parameters also displayed evident trends of change accordingly, namely, leaf parameters like leaf thickness, cuticle thickness, ratio of palisade and spongy, maximum conduit diameter, δ13C and nitrogen content per unit area increased gradually, and oppositely, leaf length-width ratio, specific leaf area, stoma length-width ratio and ratio of upper and lower epidermis to the leaf thickness decreased gradually; similarly, fruit parameters such as fruit shape index, fruit hardness, sugar-acid ratio, total color and the a/b-value ascended while the titratable acid and the hue angle descended. With increasing the altitude, the photosynthetic rate and water use efficiency of leaves were enhanced, and the fruit sugar-acid ratio climbed and the fruit flavor and color improved. Therefore, it could be safely concluded that within the altitude range between 1375 and 1715 m, environmental factors at a higher altitude favored Fuji apple growth.


Subject(s)
Altitude , Fruit/physiology , Malus/physiology , Climate , Nitrogen , Photosynthesis , Plant Leaves/physiology , Water
9.
Zhong Yao Cai ; 29(1): 60-3, 2006 Jan.
Article in Chinese | MEDLINE | ID: mdl-16722322

ABSTRACT

OBJECTIVE: To gain a clear idea on function of getting fid of cores of Cornus officinalis Sieb. et Zucc. and elect a suitable processing method and technics of Crnus officinalis Sieb. et Zucc. in producing area. METHODS: The contents of loganin and morroniside were determined in the cores and sarocarp of Cornus officinalis Sieb. et Zucc.; Using pathogonal method, the methods which Cornus officinalis sieb. et Zuee. were warmed or poached were isolated by determining quantitively loganin from Cornus officinalis Sieb. et Zucc. by HPLC. RESULTS: There was a bit loganin and morroniside in the cores of Cornus officinalis Sieb. et Zuecc.; There were three aspects that were marked influence to extracted account of loganin which were hot temperature of poach, adding water and time of warming. The best suitable extracting technology was warmed in 60 degrees C by 10 min and then getted rid of cores. CONCLUSION: Clearing the non-medicinal positon is the function of getting rid of cores of Cornus officinalis Sieb. et Zucc. and warming is better than poach.


Subject(s)
Cornus/chemistry , Iridoids/analysis , Plants, Medicinal/chemistry , Technology, Pharmaceutical/methods , Chromatography, High Pressure Liquid , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/isolation & purification , Fruit/chemistry , Glycosides/analysis , Quality Control , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL